Complex of human mTOR, also known as FRAP1 (GenBank Accession No. NM_004958), a.a. 1362-end, with N-terminal FLAG-tag, MW = 137 kDa, human MLST8 (GenBank Accession No. NM_022372), a.a. 2-326 (end) with N-terminal His-tag, MW = 37 kDa, and human Raptor (GenBank Accession No. NM_020761), a.a. 2-1335 (end) with N-terminal Histag, MW=150 kDa, co-expressed in a Baculovirus-infected Sf9 cell expression system.
40 mM Tris, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 80 ng/uL FLAG peptide, and 20% glycerol.
Species
Human
Application
Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling
Notes
Enzyme reaction is conducted in a buffer containing 50 mM HEPES (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 200 uM ATP, 0.01% Brij-35 and 2 uM substrate (Invitrogen Zlyte Ser/Thr peptide 11) at room temperature for 1 hour.
mTOR, mechanistic target of rapamycin, FRAP, FKBP-Rapamycin Associated Protein, Mammalian Target Of Rapamycin, raptor, regulatory associated protein of MTOR, Mip1, MLST8, Mammalian Lethal With SEC13 Protein 8, GBL, Gable, POP3, LST8
Uniprot
P42345 (mTOR), Q9BVC4 (MLST8), Q8N122 (Raptor)
Shipping Temperature
-80°C (dry ice)
Format
Aqueous buffer solution
Storage
At least 6 months at -80°C.
Reference
1. Toral-Barza et al., (2005) Biochem. Biophys. Res. Commun. 24, 332(1):304-10. 2. Rubio-Viqueira and Hidalgo, M. (2006) Adv. Exp. Med. Biol. 587:309-327.Application Reference(s): 1. mTOR signaling regulates nucleolar targeting of the SUMO-specific isopeptidase SENP3 (2014) 2.The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-alpha in human breast tumors in vivo (2014)